A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease.
- DOI
- 10.1002/alz.71381
- Published
- 2026 Apr
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71381,
title = {A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease.},
author = {Holper S and Barnham KJ and Churilov L and Yates P and Brodtmann A and Johns S and Li QX and Bhalala O and Chin KS and Loveland P and Yu JJ and Masters CL and Watson R and Yassi N},
year = {2026},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.71381},
url = {https://doi.org/10.1002/alz.71381}
}RIS
TY - JOUR TI - A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease. AU - Holper S AU - Barnham KJ AU - Churilov L AU - Yates P AU - Brodtmann A AU - Johns S AU - Li QX AU - Bhalala O AU - Chin KS AU - Loveland P AU - Yu JJ AU - Masters CL AU - Watson R AU - Yassi N PY - 2026 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.71381 UR - https://doi.org/10.1002/alz.71381 ER -
APA
S, H., KJ, B., L, C., P, Y., A, B., S, J., QX, L., O, B., KS, C., P, L., JJ, Y., CL, M., R, W., & N, Y. (2026). A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71381
Source records
- pubmed · retrieved 2026-09-25T08:04:46.416Z